WHO Calls for Action Against Hepatitis

WHO recommends vaccinating all children against hepatitis B infection and also adults who are at increased risk of contracting Hepatitis B.

Ahead of World Hepatitis Day on July 28, the World Health Organization on July 23 called on countries to increase their efforts to prevent viral hepatitis infections and to ensure their citizens who have been infected are diagnosed and offered treatment. Hepatitis B and C combined cause approximately 80 percent of all liver cancer deaths and kill close to 1.4 million people annually, according to WHO.

The organization wants to alert people to the risks of contracting hepatitis from unsafe blood, unsafe injections, and sharing drug-injection equipment, as well as the need for all health services to reduce risks by using only sterile equipment for injections and other medical procedures, to test all donated blood and blood components for hepatitis B and C (as well as HIV and syphilis), and to promote the use of the hepatitis B vaccine. Approximately 2 million people per year contract hepatitis from unsafe injections -- infections that could be prevented through the use of sterile syringes that are designed to prevent reuse, according to WHO.

WHO recommends vaccinating all children against hepatitis B infection and also adults who are at increased risk of contracting Hepatitis B; they include people who routinely require blood or blood products (such as dialysis patients), health care workers, people who inject drugs, household and sexual contacts of people with chronic hepatitis B, and people with multiple sexual partners.

Product Showcase

  • HAZ LO HEADLAMPS

    With alkaline or rechargeable options, these safety rated, Class 1, Div. 1 Headlamps provide long runtime with both spot and flood options in the same light. Work safely and avoid trip hazards with flexible hands-free lighting from Streamlight. Read More

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

Featured

Artificial Intelligence